Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 4,900 shares, a growth of 122.7% from the September 30th total of 2,200 shares. Based on an average daily trading volume, of 30,100 shares, the short-interest ratio is currently 0.2 days.
Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF
Large investors have recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. raised its stake in Invesco Nasdaq Biotechnology ETF by 22.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock valued at $6,156,000 after buying an additional 48,137 shares during the last quarter. Lake Street Advisors Group LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the first quarter valued at $286,000. Finally, ORG Partners LLC purchased a new position in shares of Invesco Nasdaq Biotechnology ETF in the 3rd quarter worth approximately $25,000.
Invesco Nasdaq Biotechnology ETF Stock Down 0.0 %
NASDAQ:IBBQ traded down $0.01 during trading hours on Friday, reaching $23.48. The company had a trading volume of 1,387 shares, compared to its average volume of 20,266. The firm has a market cap of $38.27 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. The business’s 50-day simple moving average is $23.98 and its two-hundred day simple moving average is $23.04. Invesco Nasdaq Biotechnology ETF has a twelve month low of $18.18 and a twelve month high of $24.84.
Invesco Nasdaq Biotechnology ETF Increases Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
See Also
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Where to Find Earnings Call Transcripts
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- When to Sell a Stock for Profit or Loss
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.